Skip to main content

Loteprednol Ophthalmic Dosage

Medically reviewed by Drugs.com. Last updated on Dec 5, 2023.

Applies to the following strengths: 0.5%; 0.2%; 0.38%; 1%; 0.25%

Usual Adult Dose for Seasonal Allergic Conjunctivitis

0.2% suspension: 1 drop instilled into the affected eye(s) four times per day

Comments:


Use: Temporary relief of the signs and symptoms of seasonal allergic conjunctivitis

Usual Adult Dose for Acne Rosacea

0.5% suspension:1 to 2 drops instilled into the conjunctival sac of the affected eye four times per day

Comments:


Use: Treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitis, when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation

Usual Adult Dose for Iritis

0.5% suspension:1 to 2 drops instilled into the conjunctival sac of the affected eye four times per day

Comments:


Use: Treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitis, when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation

Usual Adult Dose for Keratitis

0.5% suspension:1 to 2 drops instilled into the conjunctival sac of the affected eye four times per day

Comments:


Use: Treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitis, when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation

Usual Adult Dose for Conjunctivitis

0.5% suspension:1 to 2 drops instilled into the conjunctival sac of the affected eye four times per day

Comments:


Use: Treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitis, when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation

Usual Adult Dose for Cyclitis

0.5% suspension:1 to 2 drops instilled into the conjunctival sac of the affected eye four times per day

Comments:


Use: Treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitis, when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation

Usual Adult Dose for Postoperative Ocular Inflammation

0.5% ointment: A small amount (approximately 0.5 inch ribbon) should be applied into the conjunctival sac(s) four times per day beginning 24 hours after surgery and continuing throughout the first 2 weeks of the post-operative period

0.5% gel/0.5% suspension: 1 to 2 drops should be applied into the conjunctival sac of the affected eye four times per day beginning 24 hours after surgery and continuing throughout the first 2 weeks of the post-operative period

Comments:


Use: Treatment of post-operative inflammation following ocular surgery

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Storage requirements:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.